Categories
Kilitch Drugs (India) Limited — Board Meeting, 15-05-2026: Outcome of Board Meeting
15-05-2026 · 06:58 pm
Kilitch Drugs (India) Ltd. approved Q4 & FY26 consolidated results. Net sales hit ₹235.47 Cr, PAT at ₹29.50 Cr for FY26. The company also announced a 1:1 bonus share issue, doubling its equity shares.
No comments yet. Be the first to comment!